Sectoral Asset Management Inc Arcus Biosciences, Inc. Transaction History

Sectoral Asset Management Inc

$120 Million
Q3 2024

A detailed history of Sectoral Asset Management Inc transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 75,522 shares of RCUS stock, worth $1.2 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares

75,522

Previous 78,385 3.65%

Holding current value

$1.2 Million

Previous $1.19 Million 3.27%

% of portfolio

0.96%

Previous 0.59%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$13.69 - $18.01 $39,194 - $51,562	-2,863 Reduced 3.65%	75,522 $1.15 Million
Q2 2024 Aug 13, 2024	SELL	$14.59 - $18.48 $222,497 - $281,820	-15,250 Reduced 16.29%	78,385 $1.19 Million
Q1 2024 May 14, 2024	SELL	$14.83 - $20.18 $56,354 - $76,684	-3,800 Reduced 3.9%	93,635 $1.77 Million
Q4 2023 Feb 14, 2024	SELL	$13.43 - $19.63 $3.73 Million - $5.46 Million	-278,021 Reduced 74.05%	97,435 $1.86 Million
Q3 2023 Nov 14, 2023	BUY	$17.62 - $23.54 $369,420 - $493,539	20,966 Added 5.91%	375,456 $6.74 Million
Q2 2023 Aug 11, 2023	BUY	$16.97 - $22.03 $1.03 Million - $1.34 Million	60,844 Added 20.72%	354,490 $7.2 Million
Q1 2023 May 12, 2023	BUY	$15.96 - $23.15 $880,417 - $1.28 Million	55,164 Added 23.13%	293,646 $5.36 Million
Q4 2022 Feb 10, 2023	BUY	$19.7 - $35.71 $225,565 - $408,879	11,450 Added 5.04%	238,482 $4.93 Million
Q3 2022 Nov 10, 2022	SELL	$23.23 - $30.07 $1.97 Million - $2.55 Million	-84,750 Reduced 27.18%	227,032 $5.94 Million
Q2 2022 Aug 15, 2022	SELL	$17.23 - $37.73 $460,006 - $1.01 Million	-26,698 Reduced 7.89%	311,782 $7.9 Million
Q1 2022 May 10, 2022	BUY	$28.92 - $41.83 $1.6 Million - $2.31 Million	55,270 Added 19.52%	338,480 $10.7 Million
Q4 2021 Feb 11, 2022	SELL	$31.38 - $48.47 $14.3 Million - $22.1 Million	-455,800 Reduced 61.68%	283,210 $11.5 Million
Q3 2021 Nov 15, 2021	BUY	$26.93 - $37.68 $1.74 Million - $2.44 Million	64,750 Added 9.6%	739,010 $25.8 Million
Q2 2021 Aug 16, 2021	SELL	$22.75 - $35.77 $4.21 Million - $6.62 Million	-184,950 Reduced 21.53%	674,260 $18.5 Million
Q1 2021 May 14, 2021	SELL	$26.16 - $41.39 $51,012 - $80,710	-1,950 Reduced 0.23%	859,210 $24.1 Million
Q4 2020 Feb 12, 2021	SELL	$17.0 - $32.36 $1.05 Million - $1.99 Million	-61,640 Reduced 6.68%	861,160 $22.4 Million
Q3 2020 Nov 13, 2020	BUY	$17.14 - $25.47 $15.8 Million - $23.5 Million	922,800 New	922,800 $15.8 Million
Q2 2020 Aug 13, 2020	SELL	$13.97 - $36.56 $3.65 Million - $9.55 Million	-261,213 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$8.78 - $19.28 $2.29 Million - $5.04 Million	261,213 New	261,213 $3.63 Million

Others Institutions Holding RCUS

# of Institutions

200

Shares Held

51.5M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.15B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Account

Sectoral Asset Management Inc Arcus Biosciences, Inc. Transaction History